Genomate Health

Genomate Health Genomate Health is a digital health company that develops computational solutions for personalized medicine.

We’re kicking off our fall event season at the 2025 youngStartup Ventures's New York Venture Summit!Meet with Nabil Hafe...
09/05/2025

We’re kicking off our fall event season at the 2025 youngStartup Ventures's New York Venture Summit!

Meet with Nabil Hafez, CEO of Genomate Health, to discuss how Genomate applies computational reasoning to support clinical decision-making, and how we’re working to make advanced cancer care more accessible and consistent across settings.

If you're building the future of healthcare innovation, we’d love to connect.

September 9th - 10th, 2025
Javits Center, NYC
https://www.youngstartup.com/events/nyvs25/

09/03/2025

Pediatric cancer is rare, but when it strikes, it demands precision, speed, and care that’s tailored to each child’s unique case.

In a previous study published in the World Journal of Pediatrics, Genomate was evaluated for its real-world performance in pediatric oncology. The findings show that our computational reasoning platform can uncover clinically relevant, targeted therapy options, giving oncologists more clarity and more choices, even in the most complex cases. Read the study: https://link.springer.com/article/10.1007/s12519-023-00700-2

Behind every data point is a child. A family. A decision that matters.
And our mission is to make those decisions clearer, faster, and more equitable.

Some leukemia cases are straightforward. Many are not.Patients relapse. Standard therapies stop working. Decisions get h...
09/01/2025

Some leukemia cases are straightforward. Many are not.
Patients relapse. Standard therapies stop working. Decisions get harder.

That’s where Genomate comes in. We support oncologists in tackling complex leukemia cases, especially when treatment resistance, rare mutations, or time-sensitive choices make standard pathways unclear.

Our computational reasoning platform analyzes the full molecular profile of each patient’s disease and prioritizes evidence-based treatment options clinicians can act on.

Because when the case is complex, clarity isn’t a luxury. It’s a lifeline.

Learn: https://www.genomate.health/order

In our latest feature for West Midlands Life Sciences Week, we explore the growing gap between innovation and impact in ...
08/29/2025

In our latest feature for West Midlands Life Sciences Week, we explore the growing gap between innovation and impact in cancer care, and why more data alone isn’t the answer.

The problem? Inconsistent interpretation of complex molecular results.

The solution? Computational reasoning = a scalable, transparent approach to clinical decision-making that helps every patient get the right treatment, no matter where they are.

Read the full article: https://wmlifesciencesweek.co.uk/the-case-for-computational-reasoning-in-precision-oncology/

Happening today!Can precision oncology truly be equitable?Istvan Petak MD, PhD, founder and CSO of Genomate Health, is a...
08/20/2025

Happening today!

Can precision oncology truly be equitable?
Istvan Petak MD, PhD, founder and CSO of Genomate Health, is answering that question in today’s Teach Me in 10 from Technology Networks.

In just 10 minutes, he shares:
✅ Why today’s innovations often don’t reach the patients who need them
✅ How computational reasoning can help standardize care across borders
✅ What it takes to make precision oncology truly accessible

Join the event here: https://www.technologynetworks.com/tn/online-events/teach-me-in-10-future-of-molecular-diagnostics-396343?section=agenda

Next week, Dr. Peták István, founder and CSO of Genomate Health, joins Technology Networks' Teach Me in 10 to ask a toug...
08/13/2025

Next week, Dr. Peták István, founder and CSO of Genomate Health, joins Technology Networks' Teach Me in 10 to ask a tough but timely question:

𝐂𝐚𝐧 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐭𝐫𝐮𝐥𝐲 𝐛𝐞 𝐞𝐪𝐮𝐢𝐭𝐚𝐛𝐥𝐞?

In this 10-minute talk, Dr. Petak explains why today’s cutting-edge molecular diagnostics often fail to reach the patients who need them most and how Genomate’s computational reasoning approach is changing that by standardizing treatment decisions across cancer centers, from Boston to Bangladesh.

10 minutes. One mission.
📍 August 20, 2025, 6:00 PM (GMT +03:00)
Join Dr. Istvan Petak as he shares what’s needed to turn technology into impact, for every patient: https://www.technologynetworks.com/tn/online-events/teach-me-in-10-future-of-molecular-diagnostics-396343?section=speakers

You’ve been through the tests - genomic panels, scans, bloodwork, biopsies. But getting clear answers? That’s still the ...
08/06/2025

You’ve been through the tests - genomic panels, scans, bloodwork, biopsies.

But getting clear answers? That’s still the hardest part.

Most cancer data gets looked at one piece at a time. And when new results (like another NGS test) come in, it’s tough to pull everything together fast.

That’s where Genomate can help.
↘ It helps your oncologist connect the dots across all your test results
↘ Re-evaluates your options when new data comes in
↘ No extra testing, just smarter use of what you’ve already done

Ask your doctor about the Genomate Report. It could open up treatment options that were previously missed.

08/01/2025

World reminds us how urgently the world needs better, smarter answers in oncology.

Lung cancer is still the leading cause of cancer-related death globally. But many patients never get access to therapies that could help simply because it’s too hard to navigate the growing complexity of molecular testing and treatment guidelines.

At Genomate Health, we’re solving this with computational reasoning.
In a retrospective analysis of 111 lung cancer cases:
✅ 4x longer progression-free survival with Genomate’s top-ranked therapies
✅ 33% 5-year survival rate, using approved, available drugs
✅ Over 50% of patients were matched to high-scoring treatments

👉 Read the research: https://www.genomate.health/publication/genomate-real-world-performance-analysis-in-lung-cancer

When lives depend on the right decision, we can’t afford missed opportunities. Genomate helps clinicians make sense of complex, fragmented data and find optimal treatment paths - fast.

Cancer doesn’t just affect patients, it touches everyone around them.At Genomate Health, we’re constantly reminded of th...
07/30/2025

Cancer doesn’t just affect patients, it touches everyone around them.

At Genomate Health, we’re constantly reminded of the power of friendship: the friends who drive to appointments, who ask the hard questions, who sit in silence when there’s nothing to say.

Whether you're supporting someone through diagnosis, treatment, or survivorship, your presence matters more than you know.

This World Friendship Day, we honor the friends who show up, speak up, and stand by. Because while we focus on precision in treatment, they provide something just as important: presence.

If you have lungs, you can get lung cancer.And if you’ve been diagnosed, what happens next matters.Our recent study, pub...
07/24/2025

If you have lungs, you can get lung cancer.

And if you’ve been diagnosed, what happens next matters.

Our recent study, published in Nature Magazine’s npj Precision Oncology, shows that patients who received treatment recommended by Genomate lived longer, responded better, and had more treatment options based on their unique molecular profile.

Because lung cancer isn’t one-size-fits-all. And treatments shouldn’t be either.

At Genomate Health, we help oncologists look beyond the surface to highlight what matters most, flag potential resistance, and make sure no opportunity for care is missed.

Read the full study:
https://www.genomate.health/publication/genomate-real-world-performance-analysis-in-lung-cancer

07/18/2025

This simple moment - applying sunscreen before heading outside - is more than just routine.
It’s protection.
It’s prevention.
It’s care.

Most skin cancers are caused by UV exposure, and they’re often preventable with small, consistent actions like wearing sunscreen, covering up, and seeking shade.

At Genomate Health, we focus on supporting patients through some of the most complex cancer journeys, but we know that prevention is the first step in better cancer care.

This July, for , we’re honoring the small choices that protect the people we love.

A cancer diagnosis changes everything, not just for you, but for everyone who loves you. Suddenly, your world is filled ...
07/11/2025

A cancer diagnosis changes everything, not just for you, but for everyone who loves you. Suddenly, your world is filled with questions you never imagined you’d have to ask.

One thing that shouldn’t be uncertain? Whether you’re getting the best possible treatment plan for your cancer. That’s what you, your family, and your oncologist all want; and it’s what drives us at Genomate Health every single day.

Your oncologist works tirelessly to choose the right approach, often under enormous pressure. Our role is to help them see the full molecular picture, so they have the clearest information to guide every decision, no matter how complex your cancer might be.

For you, it means knowing you’re not settling for generic options. It means understanding your choices and feeling confident that your care is as personal and precise as possible.

For your doctor, it means having an extra layer of insight, highlighting what matters most and what might otherwise be missed.

And for us, it means standing behind you both, bringing clarity to complexity so you can focus on what matters most: your life, your family, your future.

Ask your care team for a Genomate® Report.

Address

Cambridge, MA

Alerts

Be the first to know and let us send you an email when Genomate Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Genomate Health:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram